Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Venus Remedies Ltd.
Swot
Venus Remedies Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Venus Remedies Ltd. has 30 Strengths, 3 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(30)
Weakness
(3)
Opportunity
(1)
Threats
(0)
Others
(4)
High DVM Mid and Small Caps (subscription)
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Companies with 10% increase in share price over three months, with rising net profit growth
Undervalued Growth Stocks
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Stocks with Consistent Share Price Growth (subscription)
Companies with high TTM EPS Growth
Best Bargains Screener: Above line growth, Below line valuations
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Affordable Stocks - Stocks with Good Trendlyne Valuation Score
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Increasing profits every quarter for the past 3 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
RSI indicating price strength
Stocks Outperforming their Industry Price Change in the Quarter
Declining Net Cash Flow : Companies not able to generate net cash
Increasing Trend in Non-Core Income
Top Losers
FII / FPI or Institutions increasing their shareholding
Strong Performers - High DVM Stocks
Bullish or Bearish Candlestick Strength - Indices
Inverted Hammer (Bullish Reversal)
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
